封面
市場調查報告書
商品編碼
1566139

心血管資訊系統市場規模、佔有率、成長分析,按系統類型、按組件、按操作模式、按最終用戶、按應用、按地區 - 行業預測,2024-2031 年

Cardiovascular Information System Market Size, Share, Growth Analysis, By System Type, By Component, By Mode of Operation, By End User, By Application, By Region - Industry Forecast 2024-2031

出版日期: | 出版商: SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格
簡介目錄

2022年心血管資訊系統市場規模將為10.21億美元,預測期內(2024-2031年)複合年成長率為7.8%,從2023年的1,106,300,000美元增加到2031年的1,106,300,0000 美元。百萬美元。

全球心血管資訊系統(CVIS)市場正在強勁成長,這主要是由於心血管疾病盛行率的上升以及對高效能患者資料管理和分析的需求不斷成長。隨著心血管疾病成為全球首要死亡原因,醫療保健提供者迫切需要利用 CVIS 來更好地管理和監測患者的心血管健康。這些系統為臨床醫生提供了先進的工具來儲存、存取和分析患者資料,最終實現更準確的診斷、客製化治療計劃和改善患者治療結果。此外,技術進步和醫療保健的廣泛數位化正在加速 CVIS 解決方案的採用。 CVIS 與電子健康記錄(EHR) 以及圖片存檔和通訊系統 (PACS) 的無縫整合可促進全面的資料交換,加強醫療保健提供者之間的協作,並實現及時的決策。但市場開拓面臨障礙。特別是,與實施和維護 CVIS 技術相關的高成本對於新興市場的醫療機構來說可能令人望而卻步。還有複雜的資料整合流程、互通性問題以及需要強大的資料安全性來保護敏感的病患資訊等挑戰。隨著醫療保健組織努力遵守資料保護條例,保護病患隱私已成為首要任務。儘管面臨這些挑戰,美國車路協同市場預計在下一個預測期內將保持持續的複合年成長率,這表明創新和投資機會持續存在。

目錄

介紹

  • 研究目的
  • 定義
  • 市場範圍

調查方法

  • 資訊採購
  • 次要/一級資訊來源
  • 市場規模預測
  • 市場假設與限制

執行摘要

  • 市場概況展望
  • 供需趨勢分析
  • 按細分市場的機會分析

市場動態及展望

  • 市場動態
    • 促進因素
    • 機會
    • 抑制因素
    • 任務
  • 波特的分析

主要市場考察

  • 關鍵成功因素
  • 競爭程度
  • 關鍵投資機會
  • 市場生態系統
  • 案例研究分析
  • PESTEL分析
  • 技術分析

心血管資訊系統市場:依系統類型

  • 市場概況
  • CVIS
  • CPACS

心血管資訊系統市場:按組成部分

  • 市場概況
  • 軟體
  • 服務
  • 硬體

心血管資訊系統市場:按營運模式

  • 市場概況
  • 網路為基礎的車路協同系統
  • 現場車路協同
  • 雲端基礎

心血管資訊系統市場:依最終用戶分類

  • 市場概況
  • 醫院
    • 小型醫院
    • 中型醫院
    • 大醫院
  • 診斷中心

心血管資訊系統市場:依應用分類

  • 市場概況
  • 導尿實驗室 CVIS 解決方案
  • 心臟超音波圖實驗室CVIS解決方案
  • 電生理實驗室CVIS解決方案
  • 核子醫學心臟病學 CVIS 解決方案
  • 心胸中心CVIS解決方案
  • 心電圖/連續型心電圖監測CVIS 解決方案
  • 心律調節器/ICD實驗室CVIS解決方案
  • 心臟衰竭中心CVIS解決方案
  • 門診CVIS解決方案
  • 其他用途

心血管資訊系統市場規模:按地區

  • 市場概況
  • 北美洲
    • 美國
    • 加拿大
  • 歐洲
    • 德國
    • 西班牙
    • 法國
    • 英國
    • 義大利
    • 其他歐洲國家地區
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 其他亞太地區
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地區
  • 中東和非洲 (MEA)
    • 海灣合作理事會國家
    • 南非
    • 其他中東/非洲地區

競爭格局

  • 前5名企業對比
  • 主要企業市場定位(2023年)
  • 主要市場參與者所採取的策略
  • 近期市集活動
  • 主要企業市場佔有率(2023年)

主要企業簡介

  • Philips Healthcare(Netherlands)
  • McKesson Corporation(US)
  • GE Healthcare(US)
  • Siemens Healthcare(Germany)
  • AGFA Healthcare(Belgium)
  • Lumedx(US)
  • Digisonics(US)
  • Fujifilm Medical Systems(Japan)
  • Meditech(US)
  • CardioComm Solutions, Inc.(Canada)
  • Medtronic plc(Ireland)
  • AliveCor, Inc.(US)
  • Hewlett Packard Enterprise(US)
  • iRhythm Technologies, Inc.(US)
  • BioTelemetry, Inc.(US)
  • Qventus(US)
  • Cardiovascular Systems, Inc.(US)
  • Telerhythmics, LLC(US)
  • Optum(US)
  • TruHearing(US)
  • Biofourmis(US)
簡介目錄
Product Code: SQMIG35A2579

Cardiovascular Information System Market size was valued at USD 1021 Million in 2022 and is poised to grow from USD 1100.63 Million in 2023 to USD 2007.22 Million by 2031, at a CAGR of 7.8% during the forecast period (2024-2031).

The global cardiovascular information system (CVIS) market is experiencing robust growth, primarily driven by the rising incidence of cardiovascular diseases and the increasing demand for efficient patient data management and analysis. As cardiovascular diseases rank among the leading causes of global mortality, there is an urgent necessity for healthcare providers to utilize CVIS for improved management and monitoring of patient cardiovascular health. These systems empower clinicians with advanced tools to store, access, and analyze patient data, ultimately leading to more accurate diagnoses, customized treatment plans, and enhanced patient outcomes. Furthermore, technological advancements and the broader digitization of healthcare are accelerating the adoption of CVIS solutions. The seamless integration of CVIS with electronic health records (EHRs) and picture archiving and communication systems (PACS) facilitates comprehensive data exchange, bolstering collaboration among healthcare providers and allowing for timely decision-making. However, the market's growth trajectory faces hurdles, particularly the high costs associated with the implementation and maintenance of CVIS technologies, which can be prohibitive for healthcare facilities in developing regions. Challenges also arise from complex data integration processes, interoperability issues, and the critical need for robust data security to protect sensitive patient information. As healthcare organizations strive to comply with data protection regulations, the focus on securing patient privacy will be paramount. Despite these challenges, the US CVIS market is anticipated to maintain a sustainable compound annual growth rate (CAGR) over the next forecast period, indicating ongoing opportunities for innovation and investment.

Top-down and bottom-up approaches were used to estimate and validate the size of the Cardiovascular Information System market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Cardiovascular Information System Market Segmental Analysis

Global Cardiovascular Information System Market is segmented by System Type, Component, Mode of Operation, End User, Application, and region. Based on System Type, the market is segmented into CVIS, and CPACS Market. Based on Component, the market is segmented into Software, Services, and Hardware. Based on Mode of Operation, the market is segmented into Web-Based CVIS, Onsite CVIS, and Cloud-Based. Based on End User, the market is segmented into Hospitals, Diagnostic Center. Based on Application, the market is segmented into Catheterization Lab CVIS Solutions, Echocardiography Lab CVIS Solutions, Electrophysiology Lab CVIS Solutions, Nuclear Cardiology CVIS Solutions, Cardiothoracic Center CVIS Solutions, ECG/Holter Monitoring CVIS Solutions, Pacemaker/ICD Lab CVIS Solutions, Heart Failure Center CVIS Solutions, Outpatient Clinic CVIS Solutions, and Other Applications. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Cardiovascular Information System Market

The increasing adoption of cloud-based solutions in the healthcare sector is a significant market driver for the Cardiovascular Information System (CVIS) market. These cloud-based CVIS solutions provide enhanced remote accessibility, allowing healthcare professionals to access critical patient data from anywhere, thus improving decision-making and patient care. Additionally, the scalability of cloud solutions caters to the diverse needs of healthcare facilities, especially smaller practices that may lack extensive IT infrastructure. Cost-effectiveness, coupled with automatic data backup, reduces operational risks and improves data security. As such, the flexibility and ease of implementation of cloud-based CVIS are compelling factors that propel their adoption, boosting overall market growth.

Restraints in the Cardiovascular Information System Market

A notable market restraint for the Cardiovascular Information System (CVIS) market lies in the substantial implementation and maintenance costs, which pose a significant barrier, particularly for smaller healthcare organizations with constrained financial resources. The financial obligations associated with CVIS encompass software licensing, necessary hardware infrastructure, comprehensive training for personnel, and ongoing technical support. For these organizations, the considerable investment required can hinder the timely adoption and integration of CVIS solutions, limiting their ability to enhance patient management and care in cardiovascular departments. Consequently, the economic strain associated with CVIS deployment remains a critical challenge in the broader healthcare landscape.

Market Trends of the Cardiovascular Information System Market

The Cardiovascular Information System (CVIS) market is experiencing a notable trend towards mobile and remote access solutions, driven by the increasing demand for flexibility and efficiency in cardiovascular care. Healthcare providers are increasingly utilizing mobile applications and secure online portals to access and review critical patient data on-the-go, enabling informed decision-making and consultations from remote locations. This trend, bolstered by the rise of telemedicine and remote patient monitoring, enhances care coordination and strengthens patient-provider communication. As healthcare continues to evolve, the integration of mobile technologies into CVIS is likely to become an essential component in delivering timely and efficient cardiovascular care.

Table of Contents

Introduction

  • Objectives of the Study
  • Definitions
  • Market Scope

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Sources
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Market Overview Outlook
  • Supply Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Dynamics
    • Drivers
    • Opportunities
    • Restraints
    • Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of Substitute Products
    • Bargaining Power of Buyers
    • Threat of New Entrants
    • Bargaining Power of Suppliers

Key Market Insights

  • Key Success Factor
  • Degree of Competition
  • Top Investment Pockets
  • Ecosystem of the Market
  • Case Study Analysis
  • PESTEL Analysis
  • Technological Analysis

Cardiovascular Information System Market by System Type

  • Market Overview
  • CVIS
  • CPACS

Cardiovascular Information System Market by Component

  • Market Overview
  • Software
  • Services
  • Hardware

Cardiovascular Information System Market by Mode of Operation

  • Market Overview
  • Web-Based CVIS
  • Onsite CVIS
  • Cloud-Based

Cardiovascular Information System Market by End User

  • Market Overview
  • Hospitals
    • Small Hospitals
    • Medium-Sized Hospitals
    • Large Hospitals
  • Diagnostic Centers

Cardiovascular Information System Market by Application

  • Market Overview
  • Catheterization Lab CVIS Solutions
  • Echocardiography Lab CVIS Solutions
  • Electrophysiology Lab CVIS Solutions
  • Nuclear Cardiology CVIS Solutions
  • Cardiothoracic Center CVIS Solutions
  • ECG/Holter Monitoring CVIS Solutions
  • Pacemaker/ICD Lab CVIS Solutions
  • Heart Failure Center CVIS Solutions
  • Outpatient Clinic CVIS Solutions
  • Other Applications

Cardiovascular Information System Market Size by Region

  • Market Overview
  • North America
    • USA
    • Canada
  • Europe
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (MEA)
    • GCC Countries
    • South Africa
    • Rest of MEA

Competitive Landscape

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2023
  • Strategies Adopted by Key Market Players
  • Recent Activities in the Market
  • Key Companies Market Share (%), 2023

Key Company Profiles

  • Philips Healthcare (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • McKesson Corporation (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • GE Healthcare (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Siemens Healthcare (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AGFA Healthcare (Belgium)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Lumedx (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Digisonics (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fujifilm Medical Systems (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meditech (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • CardioComm Solutions, Inc. (Canada)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Medtronic plc (Ireland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • AliveCor, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hewlett Packard Enterprise (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • iRhythm Technologies, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • BioTelemetry, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Qventus (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Cardiovascular Systems, Inc. (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Telerhythmics, LLC (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Optum (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • TruHearing (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Biofourmis (US)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments